
AbCellera Biologics Inc. — Investor Relations & Filings
AbCellera Biologics Inc. is a clinical-stage biotechnology company that discovers and develops antibody-based therapeutics. The company operates a proprietary, full-stack technology platform that integrates biology, computation, and engineering to search and analyze natural immune systems for therapeutic antibodies. This engine is designed to accelerate the development of first-in-class and best-in-class medicines. AbCellera advances its own internal pipeline and also partners with other pharmaceutical and biotech companies to address challenging drug discovery problems. Its capabilities support programs involving complex targets such as transmembrane proteins, bispecifics, and antibody drug conjugates for conditions with high unmet medical need.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-Q - AbCellera Biologics Inc. (0001703057) (Filer) | 2026-05-11 | English | |
| ARS - AbCellera Biologics Inc. (0001703057) (Filer) | 2026-04-29 | English | |
| DEF 14A - AbCellera Biologics Inc. (0001703057) (Filer) | 2026-04-29 | English | |
| 4 - ABCELLERA BIOLOGICS INC. (0001703057) (Filer) | 2026-03-02 | English | |
| 4 - ABCELLERA BIOLOGICS INC. (0001703057) (Filer) | 2026-02-27 | English | |
| 4 - ABCELLERA BIOLOGICS INC. (0001703057) (Filer) | 2026-02-27 | English |
Browse filings by year
9 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
13 filings
| |||||
| 45000144 | 10-Q - AbCellera Biologics Inc. (0001703057) (Filer) | 2026-05-11 | English | ||
| 38777908 | ARS - AbCellera Biologics Inc. (0001703057) (Filer) | 2026-04-29 | English | ||
| 38740788 | DEF 14A - AbCellera Biologics Inc. (0001703057) (Filer) | 2026-04-29 | English | ||
| 32896970 | 4 - ABCELLERA BIOLOGICS INC. (0001703057) (Filer) | 2026-03-02 | English | ||
| 32896971 | 4 - ABCELLERA BIOLOGICS INC. (0001703057) (Filer) | 2026-02-27 | English | ||
| 32896972 | 4 - ABCELLERA BIOLOGICS INC. (0001703057) (Filer) | 2026-02-27 | English | ||
| 32896981 | 10-K - ABCELLERA BIOLOGICS INC. (0001703057) (Filer) | 2026-02-24 | English | ||
| 32896975 | 8-K - ABCELLERA BIOLOGICS INC. (0001703057) (Filer) | 2026-02-24 | English | ||
| 13026668 | 8-K | 2026-01-14 | English | ||
| 13026671 | FORM 4 | 2026-01-05 | English | ||
| 13026672 | FORM 4 | 2026-01-05 | English | ||
| 13026679 | FORM 4 | 2026-01-05 | English | ||
| 13026674 | FORM 4 | 2026-01-05 | English | ||
|
2025
2 filings
| |||||
| 13026673 | FORM 4 | 2025-12-19 | English | ||
| 13026680 | FORM 3 | 2025-12-19 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
89bio, Inc.
Clinical-stage biopharma developing therapies for liver and…
|
ETNB | US | Manufacturing |
|
Aardvark Therapeutics, Inc.
Clinical-stage biopharma developing therapeutics for hunger…
|
AARD | US | Manufacturing |
|
Aarey Drugs & Pharmaceuticals Ltd
Manufactures APIs and chemical intermediates for global pha…
|
AAREYDRUGS | IN | Manufacturing |
|
Aarti Drugs Limited
Produces APIs, pharma intermediates, and specialty chemical…
|
AARTIDRUGS | IN | Manufacturing |
|
Aarti Pharmalabs Limited
Manufacturer of APIs, intermediates, and xanthines with glo…
|
AARTIPHARM | IN | Manufacturing |
|
AAYUSH WELLNESS LIMITED
Develops and markets herbal formulations, supplements, and …
|
539528 | IN | Manufacturing |
|
Ab&B Bio-Tech CO., LTD. JS
Biopharmaceutical company engaged in the R&D and commercial…
|
2627 | HK | Manufacturing |
|
Abbisko Cayman Limited
Clinical-stage biopharma focused on discovering and develop…
|
2256 | KY | Manufacturing |
|
Abbott India Ltd.
Provides pharmaceutical solutions in gastroenterology, card…
|
ABBOTINDIA | IN | Manufacturing |
|
ABBOTT LABORATORIES
Global healthcare company in medical devices, diagnostics, …
|
ABT | US | Manufacturing |
AbCellera Biologics Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/31942/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=31942 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=31942 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=31942 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 31942}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for AbCellera Biologics Inc. (id: 31942)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.